Praram 9 Hospital PCL (BKK:PR9)

Thailand · Delayed Price · Currency is THB

17.80

+0.10 (0.56%)

Jul 24, 2026, 4:35 PM ICT

-26.75% (1Y)

Market Cap	14.00B -26.7%
Revenue (ttm)	5.39B +10.9%
Net Income	806.77M +7.0%
EPS	1.03 +7.0%
Shares Out	786.30M
PE Ratio	17.35
Forward PE	16.11
Dividend	0.50 (2.82%)
Ex-Dividend Date	Apr 30, 2026

Volume	2,483,847
Open	17.70
Previous Close	17.70
Day's Range	17.40 - 17.80
52-Week Range	15.70 - 25.25
Beta	0.13
Analysts	Strong Buy
Price Target	22.72 (+27.64%)
Earnings Date	Aug 7, 2026

About Praram 9 Hospital PCL

Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal and liver disease, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as vaccination and travel medicine, and traditional... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1992

Employees 1,558

Stock Exchange Stock Exchange of Thailand

Ticker Symbol PR9

Full Company Profile

Financial Performance

In 2025, Praram 9 Hospital PCL's revenue was 5.34 billion, an increase of 13.88% compared to the previous year's 4.69 billion. Earnings were 822.71 million, an increase of 15.44%.

Financial Statements

Analyst Summary

According to 14 analysts, the average rating for PR9 stock is "Strong Buy." The 12-month stock price target is ฿22.72, which is an increase of 27.64% from the latest price.

Price Target

฿22.72

(27.64% upside)

Analyst Consensus: Strong Buy

Stock Forecasts